The capacity of CS to alter mucin production was reported in human lungs affected by chronic obstructive pulmonary disease (COPD) (Di et al., 2012; Kim, 2012) and in guinea pig airways (Pini et al., 2016b). The gene discussed is MUC5AC; the disease is chronic obstructive pulmonary disease.